Titlebook: Drug Repurposing; Innovative Approache Naveen Chella,Om Prakash Ranjan,Amit Alexander Book 2024 The Editor(s) (if applicable) and The Autho

Ancestor

Drug Repurposing in Inflammatory Disorders,me other medical conditions. It is essential because it may significantly save the time, expense, and risk involved in creating new medications from scratch while offering new therapeutic alternatives to patients with unmet medical requirements. Drug repurposing offers several compelling advantages

輪流

condescend

Reshaping the Therapeutic Landscape: Drug Repurposing for Emerging Infectious Diseases and Rare Diseases include alkaptonuria, Ehlers-Danlos syndrome, neurofibromatosis, and hereditary angioedema. Patients with rare diseases frequently experience significant challenges getting a prompt and correct diagnosis, getting appropriate treatments, and acquiring support from the healthcare system due to t

繼而發(fā)生

MAL

abolish

Commemorate

inflame

have shown positive results. Even some anticancer agents confirmed their potential effects in other cancers. Here, data mining approaches have been found rationale to provide strength in the repurposing pipeline. Especially if dose compatibility of the repurposed candidate is found for anticancer t

Catheter

ge or infection and is involved in the pathophysiology of almost all diseases. But inflammation can turn into the dark side of the sword when it affects healthy tissues or extends to the body as a whole for a long time, referred to as chronic inflammation. Even though there are various treatments fo

雀斑

https://doi.org/10.1007/978-94-011-9839-4 computational approaches. In addition, a few case studies involving drug repurposing for specific CNS disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Amyotrophic lateral sclerosis, Spinal muscular atrophy, and Epilepsy are presented in this chapter.